Journal
CANADIAN JOURNAL OF CARDIOLOGY
Volume 31, Issue 11, Pages 1309-1312Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cjca.2015.06.034
Keywords
-
Categories
Funding
- US NIH [R01HL128857]
Ask authors/readers for more resources
The genetic evaluation of dilated cardiomyopathy (DCM) has been challenging, owing in large part to marked genetic heterogeneity. However, lower costs from next-generation sequencing have enabled gene discovery and the expansion of genetic testing panels. These advances have improved molecular diagnostics and predictive testing in DCM. We provide a rationale and recommendation for clinical genetic testing in all DCM cases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available